A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase 1/2 randomised placebo-controlled study of the COVID-19 vaccine mRNA-1273 in healthy Japanese adults: An interim report

Published:2022-03 Issue:13 Volume:40 Page:2044-2052
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Masuda Taisei,Murakami Kyoko,Sugiura Kenkichi,Sakui Sho,Philip Schuring Ron,Mori Mitsuhiro

Funder

Takeda Pharmaceutical Co Ltd

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference12 articles.

1. Evaluation of mRNA-1273 SARS-CoV-2 vaccine in adolescents;Ali;N Engl J Med,2021

2. Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults;Anderson;N Engl J Med,2020

3. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

4. A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine;Chu;Vaccine,2021

5. Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates;Corbett;N Engl J Med,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A/B testing: A systematic literature review;Journal of Systems and Software;2024-05

2. Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations;Frontiers in Immunology;2024-01-31

3. A Critical Assessment of COVID-19 Genomic Vaccines;Current Topics in Medicinal Chemistry;2023-10

4. Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine;Expert Review of Vaccines;2023-09-25

5. Comparative Immunogenicity, Safety and Efficacy Profiles of four COVID-19 Vaccine types in healthy adults: Systematic Review cum Meta-analysis of Clinical Trial data;2023-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3